Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cell Reports Methods
|
February 27, 2024
Decomprolute is a benchmarking platform designed for multiomics-based tumor deconvolution
Song Feng, Anna Calinawan, Pietro Pugliese, et al.
Cell Reports. Medicine
|
August 15, 2023
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Joshua M Wang, Runyu Hong, Elizabeth G Demicco, et al.
Cell Reports. Medicine
|
January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
Dongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Cell
|
August 15, 2023
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell
|
February 16, 2024
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Cell
|
August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Cell Reports. Medicine
|
May 4, 2024
Comprehensive proteogenomic characterization of rare kidney tumors
Ginny Xiaohe Li, Lijun Chen, Yi Hsiao, et al.
Cell
|
February 15, 2024
Pan-cancer proteogenomics characterization of tumor immunity
Francesca Petralia, Weiping Ma, Tomer M Yaron, et al.
Cancer Cell
|
December 23, 2022
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Yize Li, Tung-Shing M Lih, Saravana M Dhanasekaran, et al.
Cell
|
January 11, 2020
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
David J Clark, Saravana M Dhanasekaran, Francesca Petralia, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cell Reports Methods
|
February 27, 2024
Decomprolute is a benchmarking platform designed for multiomics-based tumor deconvolution
Song Feng, Anna Calinawan, Pietro Pugliese, et al.
Cell Reports. Medicine
|
August 15, 2023
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Joshua M Wang, Runyu Hong, Elizabeth G Demicco, et al.
Cell Reports. Medicine
|
January 14, 2022
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
Dongqing Huang, Shrabanti Chowdhury, Hong Wang, et al.
Cell
|
August 15, 2023
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell
|
February 16, 2024
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Cell
|
August 4, 2023
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Shrabanti Chowdhury, Jacob J Kennedy, Richard G Ivey, et al.
Cell Reports. Medicine
|
May 4, 2024
Comprehensive proteogenomic characterization of rare kidney tumors
Ginny Xiaohe Li, Lijun Chen, Yi Hsiao, et al.
Cell
|
February 15, 2024
Pan-cancer proteogenomics characterization of tumor immunity
Francesca Petralia, Weiping Ma, Tomer M Yaron, et al.
Cancer Cell
|
December 23, 2022
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Yize Li, Tung-Shing M Lih, Saravana M Dhanasekaran, et al.
Cell
|
January 11, 2020
Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
David J Clark, Saravana M Dhanasekaran, Francesca Petralia, et al.
Page
of 2